Navigation Links
Mauna Kea Technologies Announces Highlights of Third International Conference of Cellvizio Users (ICCU)

NICE, France, April 11, 2011 /PRNewswire/ -- Mauna Kea Technologies today announced highlights from the 3rd Annual International Conference of Cellvizio® Users (ICCU).  The meeting included 32 different speakers and 25 posters on the role and impact of probe-based confocal laser endomicroscopy (pCLE) with Cellvizio in diagnosing, treating and managing patients with gastrointestinal (GI) and lung diseases.

Cellvizio provides physicians with a cellular-level view of living tissue inside the body during standard endoscopy exams. Over 95 experts from 12 countries and a variety of specialties, including digestive and pulmonary endoscopy, urology, pathology and image processing, attended the meeting, which was held in Nice, France from April 8-10.

"Mounting evidence and clinical experience show that pCLE will change the way disease is diagnosed and treatment decided upon," said ICCU 2011 co-chair Jean-Paul Galmiche, MD, FRCP, Professor of Medicine, Nantes University Hospital, Nantes, France. "ICCU provided an ideal forum for pCLE users to discuss new findings and draw conclusions regarding how to accurately interpret Cellvizio images, integrate the technology into our practices and manage patients more effectively."

The program for this conference was designed for Cellvizio users to build on the knowledge physicians have obtained from current clinical practice, discuss new major study results and build consensus on image interpretation and best practices.  Attendees participated in the largest interactive pCLE image interpretation workshop to date, as well as a hands-on workshop and live demonstrations at the Princess Grace Hospital in Monaco.

"The community of pCLE users is working together to increase its understanding and advance the science of this important visualization tool in clinical applications where we require faster, and more accurate diagnosis," said ICCU 2011 co-chair Prateek Sharma, MD, Professor of Medicine, University of Kansas School of Medicine, Kansas City, Kansas, USA. "When using pCLE to monitor patients with Barrett's esophagus, a condition that is a pre-cursor for esophageal cancer, we're able to effectively diagnose disease which can lead to targeted treatment of pre-cancerous tissue during the endoscopy procedure."

New unpublished data were announced at the meeting, including the results of the company's Cellvizio ERCP registry trial designed to determine pCLE impact on the diagnosis and treatment of patients with biliary strictures. The results of a major study investigating whether pCLE imaging helps physicians confirm that they have eliminated all pre-cancerous cells after performing endoscopic mucosal resection (EMR) procedures to remove colon polyps and surrounding tissue were also presented.

Results of both trials and numerous others will be presented publicly at Digestive Disease Week (DDW) in Chicago, May 8-10.  To date, DDW has accepted 33 pCLE-related abstracts, including 11, which will be delivered through oral presentations.

Separately, pulmonologists who attended the meeting are planning a white paper to outline image interpretation of pCLE images in the lung, as well as proposed treatment algorithms.

During the meeting, the company also announced that Jayant Talreja, M.D., University of Virginia Medical Center, is the first recipient of the Yang K. Chen Fellowship Research Grant Award. Mauna Kea Technologies established this program to commemorate Pr. Chen's significant contribution to medical practice, notably his important efforts to improve the diagnosis and treatment of patients with suspected bile duct and pancreatic diseases.

The company has sponsored 24 training courses in the last 12 months and hosts the ICCU annually so that members of the Cellvizio community can come together to share clinical experiences, discuss image interpretation, participate in training and reach consensus on the use of Cellvizio in routine clinical practice.

"Mauna Kea Technologies has dedicated itself to providing physicians forums through which they can help each other understand and utilize pCLE and benefit from the advantages of accurate disease characterization," said Sacha Loiseau, PhD, President, CEO and founder, Mauna Kea Technologies.  "The outstanding ICCU faculty members once again designed a scientific program to enrich the knowledge and clinical skills of their colleagues in managing and treating patients with GI and lung disease. We look forward to advancing this discussion at future events, notably at DDW next month."

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company and a leader in endomicroscopic innovation. The company researches, develops and markets innovative tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts. Its flagship product, Cellvizio®, a probe-based Confocal Laser Endomicroscopy (pCLE) system, provides physicians and researchers high resolution cellular views of tissue inside the body. Large, international, multi-center clinical trials have demonstrated Cellvizio's ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce costs within a hospital, Cellvizio can be used with almost any endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the GI and pulmonary tracts.

For more information about Mauna Kea Technologies visit

SOURCE Mauna Kea Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
2. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
3. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
4. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
5. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can actually ... conceived of this design due to personal experience with a bad back," he said. ... and convenience, as well as increases support. It also makes it easier to eat, ...
(Date:11/28/2015)... Viejo, CA (PRWEB) , ... November 28, 2015 , ... ... new fully customizable media panels to choose from, the possibilities are endless. Users have ... and more. With the ProPanel: Pulse masking effects, users are sure to get heads ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... they are handling security in light of the recent terrorist attacks in Paris, other ... to stop an attack from reaching U.S. soil. Especially around special events that may ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors ... treat it. Surviving Mesothelioma has just posted the findings on the website. Click ... analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed by ...
Breaking Medicine News(10 mins):